Skip to content

ANI PHARMACEUTICALS, INC: 10-K filed 2013-02-28

What ANI PHARMACEUTICALS, INC reported in its annual report filed 2013-02-28 (fiscal FY 2012): 29 published measures, 112 facts as tagged in accession 0001104659-13-016148.

This filing

Form
10-K (annual report)
Filed
2013-02-28
Fiscal period
fiscal FY 2012
Accession
0001104659-13-016148 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ANI PHARMACEUTICALS, INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-12-3138,769,170USD
At 2011-12-3162,379,755USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-12-3110,593,665USD
At 2011-12-3124,564,463USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-12-3128,175,505USD
At 2011-12-3137,815,292USD
At 2010-12-3119,147,122USD
At 2009-12-3115,830,394USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-12-3134,794,341USD
At 2011-12-3157,225,234USD
At 2010-12-3138,155,251USD
At 2009-12-3129,858,465USD

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-12-31611,193USD366
2011-01-01 to 2011-12-31719,925USD365
2010-01-01 to 2010-12-3163,441USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-10-01 to 2012-12-311,967,573USD92
2012-01-01 to 2012-12-312,300,736USD366
2012-07-01 to 2012-09-30110,383USD92
2012-04-01 to 2012-06-30108,780USD91
2012-01-01 to 2012-03-31114,000USD91
2011-10-01 to 2011-12-31114,373USD92
2011-01-01 to 2011-12-31435,160USD365
2011-07-01 to 2011-09-30182,784USD92
2011-04-01 to 2011-06-3081,003USD91
2011-01-01 to 2011-03-3157,000USD90
2010-01-01 to 2010-12-312,474,237USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-12-31-244,956,887USD
At 2011-12-31-217,239,148USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2012-01-01 to 2012-12-3121,757,906shares366
2011-01-01 to 2011-12-3116,397,618shares365
2010-01-01 to 2010-12-3110,985,291shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-01-01 to 2012-12-3121,757,906shares366
2011-01-01 to 2011-12-3116,397,618shares365
2010-01-01 to 2010-12-3110,985,291shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-1.27USD/shares366
2011-01-01 to 2011-12-31-3.15USD/shares365
2010-01-01 to 2010-12-31-4.21USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-1.27USD/shares366
2011-01-01 to 2011-12-31-3.15USD/shares365
2010-01-01 to 2010-12-31-4.21USD/shares365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-121,791USD366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-12-31166,386USD
At 2011-12-31861,364USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-01-01 to 2012-12-31725,625USD366
2011-01-01 to 2011-12-311,177,683USD365
2010-01-01 to 2010-12-31992,757USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-3,635,228USD92
2012-07-01 to 2012-09-30-5,334,966USD92
2012-04-01 to 2012-06-30-7,269,453USD91
2012-01-01 to 2012-03-31-6,931,935USD91
2011-10-01 to 2011-12-31-8,340,710USD92
2011-07-01 to 2011-09-30-13,028,207USD92
2011-04-01 to 2011-06-30-13,064,942USD91
2011-01-01 to 2011-03-31-16,442,921USD90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-12-3135,173,144USD
At 2011-12-3158,026,381USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-01-01 to 2012-12-31348,019USD366
2011-01-01 to 2011-12-31681,573USD365
2010-01-01 to 2010-12-31688,083USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-12-3110,593,665USD
At 2011-12-317,227,703USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-12-311,128,644USD
At 2011-12-313,150,677USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-10-01 to 2012-12-312,514,591USD92
2012-01-01 to 2012-12-3116,888,849USD366
2012-07-01 to 2012-09-303,822,736USD92
2012-04-01 to 2012-06-305,398,305USD91
2012-01-01 to 2012-03-315,153,217USD91
2011-10-01 to 2011-12-316,701,465USD92
2011-01-01 to 2011-12-3144,182,260USD365
2011-07-01 to 2011-09-3011,500,053USD92
2011-04-01 to 2011-06-3011,116,323USD91
2011-01-01 to 2011-03-3114,864,420USD90
2010-01-01 to 2010-12-3139,705,502USD365

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-12-31557,948USD
At 2011-12-311,287,453USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-12-31391,562USD
At 2011-12-31426,089USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-12-31378,803USD
At 2011-12-31801,147USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2012-01-01 to 2012-12-31-27,839,530USD366
2011-01-01 to 2011-12-31-51,608,504USD365
2010-01-01 to 2010-12-31-46,196,216USD365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-3,987,331USD92
2012-01-01 to 2012-12-31-27,717,739USD366
2012-07-01 to 2012-09-30-6,121,815USD92
2012-04-01 to 2012-06-30-7,344,116USD91
2012-01-01 to 2012-03-31-10,264,477USD91
2011-10-01 to 2011-12-31-6,648,906USD92
2011-01-01 to 2011-12-31-51,608,504USD365
2011-07-01 to 2011-09-30-12,733,691USD92
2011-04-01 to 2011-06-30-14,975,231USD91
2011-01-01 to 2011-03-31-17,250,676USD90
2010-01-01 to 2010-12-31-46,196,216USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-10-01 to 2012-12-312,901,812USD92
2012-01-01 to 2012-12-318,229,523USD366
2012-07-01 to 2012-09-301,546,864USD92
2012-04-01 to 2012-06-301,948,995USD91
2012-01-01 to 2012-03-311,831,852USD91
2011-10-01 to 2011-12-311,723,562USD92
2011-01-01 to 2011-12-316,981,490USD365
2011-07-01 to 2011-09-301,675,268USD92
2011-04-01 to 2011-06-301,989,103USD91
2011-01-01 to 2011-03-311,593,557USD90
2010-01-01 to 2010-12-315,940,360USD365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2012-01-01 to 2012-12-31258,946USD366
2011-01-01 to 2011-12-31148,240USD365
2010-01-01 to 2010-12-31167,986USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-01-01 to 2012-12-313,260,865USD366
2011-01-01 to 2011-12-3123,876,370USD365
2010-01-01 to 2010-12-3148,452,644USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2010-01-01 to 2010-12-3164,645USD365

Inspect the source

Entity
ANI PHARMACEUTICALS, INC / CIK 0001023024
Captured
2026-09-20T05:13:47.462Z
SEC response SHA-256
73f151e92444492f6e76683dd14e436bd7ae49ff3f0c015ea516484800094ee5

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001023024.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))